Global /Hong Kong /Healthcare /Medical Devices /8622

Joyzyme Group Ltd.

8622

• SHEK: 8622 • Delayed

0.3400HKD 1.5%

0.0434 USD

As of 7 June 2026, Joyzyme Group Ltd. has a market cap of $22.04M USD, ranking #36445 globally and #1034 in Hong Kong. It ranks #3274 in the Healthcare sector, and #693 in the Medical Devices industry.

Global Rank

36445

Country Rank

1034

Sector Rank

3274

Industry Rank

693

Key Stats

Market Cap

$22.04MUSD

172.68M HKD

Enterprise Value

$16.79MUSD

131.56M HKD

Revenue (TTM)

$4.02MUSD

31.47M HKD

EBITDA (TTM)

-$904.25KUSD

-7.09M HKD

Net Income (TTM)

-$710.99KUSD

-5.57M HKD

EBITDA Margin

-23%

Profit Margin

-18%

PS Ratio

5.5

PB Ratio

3.0

Company Profile

Country (HQ)

Hong Kong

Sector

Healthcare

Industry

Medical Devices

CEO

Chunguang Zhang open_in_new

Employees

101

Founded

1992

Website

joyzymebiotech.com/en/ open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.5%	9%	8.1%	-15%	-48%	-23%	-6.9%	83%	253%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	8622 华康生物医学控股有限公司 ISIN: KYG4644W1069 Shares Out.: Shares Outstanding: 515.472M¹ Shares Float: 159.796M² TV: TradingView: HKEX: 8622 SA: Stock Analysis: HKG: 8622 YF: Yahoo Finance: 8622.HK GF: Google Finance: HKG: 8622 BA: Barron's: 8622 MS: Morningstar: XHKG: 08622	0.3400 HKD	TV: TradingView: HKEX: 8622 SA: Stock Analysis: HKG: 8622 YF: Yahoo Finance: 8622.HK GF: Google Finance: HKG: 8622 BA: Barron's: 8622 MS: Morningstar: XHKG: 08622

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Joyzyme Group Ltd.

Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. The company was formerly known as Huakang Biomedical Holdings Company Limited and changed its name to Joyzyme Group Limited in January 2026. Joyzyme Group Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.

Similar Companies

Industry: Medical Devices (Hong Kong)

Name	Market Cap (USD) diff.	PE	Country
Modern Dental Group Ltd. SHEK: 3600	$733.78M 5.75B HKD 3K%	9.7	Hong Kong
OrbusNeich Medical Group Holdings Ltd. SHEK: 6929	$404.52M 3.17B HKD 2K%	9.7	Hong Kong
Essex Bio-Technology Ltd. SHEK: 1061	$230.85M 1.81B HKD 947%	5.7	Hong Kong
Uni-Bio Science Group Ltd. SHEK: 690	$73.16M 573.24M HKD 232%	6.2	Hong Kong
Vincent Medical Holdings Ltd. SHEK: 1612	$71.53M 560.49M HKD 225%	5.3	Hong Kong
Kaisa Health Group Holdings Ltd. SHEK: 876	$68.21M 534.47M HKD 210%	-	Hong Kong

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 786K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 729K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 722K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 574K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 548K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 462K%	22.2	Ireland

chevron_leftBack